The 37th annual San Antonio Breast Cancer Symposium (SABCS) is currently underway in San Antonio, running from December 9 to 13 at the Henry B. Gonzalez Convention Center. The symposium is presented by Cancer Therapy & Research Center at the UT Health Science Center in San Antonio, the American Association for Cancer Research, and Baylor College of Medicine.
Each year during the second week of December, the San Antonio Breast Cancer Symposium hosts thousands of participants from the breast cancer field to discuss new advances in research regarding the disease. More than 7,500 experts from all over the world come together to participate in the San Antonio Breast Cancer Symposium to analyze recent developments, such as favorable, new triple-negative breast cancer perspectives and issues such as the increasing number of prophylactic mastectomies. The symposium represents an economic impact of $19 million.
Symposium co-director Ismail Jatoi, M.D., Ph.D., chief of surgical oncology at the UTHealth Science Center San Antonio said: “Even as treatments improve and the rate of breast cancer recurrence is decreasing, women are increasingly choosing to have the healthy breast removed at the same time as the one with cancer. This is a perplexing trend.”
This year’s speakers include Dr. Mary-Claire King, Ph.D., who has conducted remarkable research regarding the role of the BRCA1 gene. Dr. King demonstrated that BRCA1 is responsible for both breast and ovarian cancer in many families. This discovery of BRCA1 revolutionizes how common inherited diseases will be studied.